rofecoxib has been researched along with Recrudescence in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the risk of death and recurrent congestive heart failure in elderly patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs (NSAIDs) and to determine whether there are class differences between celecoxib and rofecoxib." | 7.73 | Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study. ( Hudson, M; Pilote, L; Richard, H, 2005) |
| "Rofecoxib appears to control arthralgia in almost two-thirds of inflammatory bowel disease patients." | 5.11 | Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. ( Biancone, L; Emerenziani, S; Fina, D; Geremia, A; Pallone, F; Petruzziello, C; Tosti, C, 2004) |
| " Three subjects with multiple-drug induced urticaria complained of a generalized reaction after challenge (Two due to celecoxib and one due to meloxicam)." | 5.11 | Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. ( Antonicelli, L; Bilò, MB; Bonadonna, P; Crivellaro, MA; Dama, AR; Schiappoli, M; Senna, G, 2004) |
| "Evaluate aspirin challenge as a means to distinguish single from multiple NSAID intolerance in patients with a clinical history of acute urticaria induced by a single NSAID." | 5.11 | Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. ( Asero, R, 2005) |
| "Although only rofecoxib use was associated with an increased risk of myocardial infarction in those without a previous event, both rofecoxib and celecoxib were associated with an excess risk of acute myocardial infarction for current users with a history of myocardial infarction." | 3.74 | The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction. ( Brophy, JM; Lévesque, LE; Zhang, B, 2007) |
| "To compare the risk of death and recurrent congestive heart failure in elderly patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs (NSAIDs) and to determine whether there are class differences between celecoxib and rofecoxib." | 3.73 | Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study. ( Hudson, M; Pilote, L; Richard, H, 2005) |
| "Rizatriptan is an effective and fast acting drug for the acute treatment of migraine." | 2.70 | Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. ( Barbosa, JS; Krymchantowski, AV, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peres, MF | 1 |
| Silberstein, SD | 1 |
| Plikat, K | 1 |
| Reichle, A | 1 |
| Elmlinger, MW | 1 |
| Schölmerich, J | 1 |
| Lisotto, C | 1 |
| Maggioni, F | 1 |
| Mainardi, F | 1 |
| Zanchin, G | 1 |
| Spiegel, BM | 1 |
| Targownik, L | 1 |
| Dulai, GS | 1 |
| Gralnek, IM | 1 |
| Ashwath, ML | 1 |
| Katner, HP | 1 |
| Biancone, L | 2 |
| Tosti, C | 2 |
| De Nigris, F | 1 |
| Fantini, M | 1 |
| Pallone, F | 2 |
| James, MW | 1 |
| Hawkey, CJ | 1 |
| Geremia, A | 1 |
| Fina, D | 1 |
| Petruzziello, C | 1 |
| Emerenziani, S | 1 |
| Senna, G | 1 |
| Bilò, MB | 1 |
| Antonicelli, L | 1 |
| Schiappoli, M | 1 |
| Crivellaro, MA | 1 |
| Bonadonna, P | 1 |
| Dama, AR | 1 |
| Hudson, M | 1 |
| Richard, H | 1 |
| Pilote, L | 1 |
| Asero, R | 1 |
| Gislason, GH | 1 |
| Jacobsen, S | 1 |
| Rasmussen, JN | 1 |
| Rasmussen, S | 1 |
| Buch, P | 1 |
| Friberg, J | 1 |
| Schramm, TK | 1 |
| Abildstrom, SZ | 1 |
| Køber, L | 1 |
| Madsen, M | 1 |
| Torp-Pedersen, C | 1 |
| Brophy, JM | 1 |
| Lévesque, LE | 1 |
| Zhang, B | 1 |
| Mor, M | 1 |
| Niv, G | 1 |
| Niv, Y | 1 |
| Lapner, MA | 1 |
| Stephen, WJ | 1 |
| McGettigan, P | 1 |
| Han, P | 1 |
| Jones, L | 1 |
| Whitaker, D | 1 |
| Henry, D | 1 |
| Simon, B | 1 |
| Hunt, RH | 1 |
| Barkun, AN | 1 |
| Baron, D | 1 |
| Bombardier, C | 1 |
| Bursey, FR | 1 |
| Marshall, JR | 1 |
| Morgan, DG | 1 |
| Paré, P | 1 |
| Thomson, AB | 1 |
| Whittaker, JS | 1 |
| Goh, J | 1 |
| Wight, D | 1 |
| Parkes, M | 1 |
| Middleton, SJ | 1 |
| Hunter, JO | 1 |
| Krymchantowski, AV | 1 |
| Barbosa, JS | 1 |
3 reviews available for rofecoxib and Recrudescence
| Article | Year |
|---|---|
The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Celecoxib; | 2003 |
Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2003 |
Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase Inhibitors; Dose | 2002 |
4 trials available for rofecoxib and Recrudescence
| Article | Year |
|---|---|
Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Colitis, Ulcerative; Crohn Disease | 2004 |
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celec | 2004 |
Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs.
Topics: Acetaminophen; Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anal | 2005 |
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, | 2002 |
14 other studies available for rofecoxib and Recrudescence
| Article | Year |
|---|---|
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Lactones; Male; Migraine Disorde | 2002 |
[Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alky | 2003 |
Rofecoxib for the treatment of chronic paroxysmal hemicrania.
Topics: Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Lactones; Male; Recurrence; Sulfones; Vascu | 2003 |
Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Chronic Disease; Cost-Ben | 2003 |
Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lactones; Meningitis, Aseptic; Recur | 2003 |
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease.
Topics: Adult; Aged; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Infla | 2003 |
Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cause of Death; Celecoxib; Cohort Studies; Cyclooxyge | 2005 |
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Confidence Intervals; C | 2006 |
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction.
Topics: Aged; Case-Control Studies; Celecoxib; Confounding Factors, Epidemiologic; Cyclooxygenase 2 Inhibito | 2007 |
Patient retention in a clinical trial: a lesson from the rofecoxib (VIOXX) study.
Topics: Aged; Aged, 80 and over; Colonic Polyps; Cyclooxygenase 2 Inhibitors; Female; Humans; Lactones; Male | 2006 |
Rofecoxib associated with diaphragm disease.
Topics: Arthritis, Rheumatoid; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors; Female; Humans; Intest | 2007 |
Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Celecoxib; C | 2008 |
[Prof. Bernd Simon on nonsteroidal anti-inflammatory drugs. Gastrointestinal complications are unpredictable].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Humans; Lactones; Peptic Ulcer; | 2001 |
Rofecoxib and cytomegalovirus in acute flare-up of ulcerative colitis: coprecipitants or coincidence?
Topics: Aged; Colitis, Ulcerative; Cyclooxygenase Inhibitors; Cytomegalovirus Infections; Humans; Lactones; | 2002 |